A detailed history of Cibc Private Wealth Group, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 775 shares of PBYI stock, worth $2,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
775
Previous 775 -0.0%
Holding current value
$2,371
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.29 - $7.4 $3,324 - $5,735
775 New
775 $4,000
Q3 2018

Nov 14, 2018

SELL
$41.2 - $59.85 $29,870 - $43,391
-725 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$48.3 - $68.25 $28,497 - $40,267
590 Added 437.04%
725 $43,000
Q1 2018

May 17, 2018

SELL
$59.7 - $99.25 $19,581 - $32,554
-328 Reduced 70.84%
135 $9,000
Q4 2017

Feb 12, 2018

BUY
$93.85 - $132.45 $43,452 - $61,324
463
463 $46,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $139M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.